S100A9 and neoplasm: Lv et al. indicated that S100A9 binds to TLR4, activating the NF-κB pathway to stimulate tumor cells to secrete fibronectin, and subsequently activating integrin β1-focal adhesion kinase, which is involved in prostate cancer cell invasion 40.